Global Non-PVC IV Bags Market

Non-PVC IV Bags Market Size, Share, Growth Analysis, By Product(Single Chamber, Multi Chamber), By Material(Ethylene Vinyl Acetate, Polypropylene) - Industry Forecast 2024-2031

Report ID: SQMIG35B2050 | Region: Global | Published Date: July, 2036
Pages: 157 | Tables: 64 | Figures: 75

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Non-PVC IV Bags Market size was valued at USD 1.69 billion in 2019 and is poised to grow from USD 1.73 billion in 2023 to USD 3.97 billion by 2031, growing at a CAGR of 10.9% in the forecast period (2024-2031).

non-PVC IV bags market is relatively fragmented, with a high level of competition. Many businesses are putting an emphasis on organic growth initiatives, including new launches, product approvals, and others like patents and events. Acquisitions and partnerships & collaborations were two examples of inorganic growth tactics in the market. These actions have made it possible for market participants to grow their consumer bases and operations. With the increasing demand for non-PVC IV bags in the industry, it is projected that market participants for non-PVC IV bags would have profitable growth prospects in the future.  'Baxter', 'B. Braun Melsungen AG ', 'Fresenius Kabi AG ', 'Sippex IV bag manufacturing co.', 'PolyCine GmbH', 'Renolit', 'Angiplast Pvt. Ltd.', 'Kraton Corporation', 'ICU Medical, Inc.', 'Hospira, Inc.', 'Wipak Medical', 'Novapax', 'Shenzhen Huaxin Plastic Products Co., Ltd.', 'Shanghai Solve Care Co., Ltd.', 'Hubei Huaqiang High Performance Material', 'Shanghai Jieyi Biotechnology Co., Ltd.', 'Ciron Drugs & Pharmaceuticals Pvt. Ltd.', 'Qosina Corp', 'Argo Medical', 'Medline Industries, Inc.'

Since chemotherapy involves administering drugs orally or intravenously (IV), factors such the rising cancer prevalence are anticipated to fuel market expansion throughout the forecast period. For instance, the World Health Organization (WHO) reports that cancer is the second biggest cause of death worldwide.

According to predictions, the use of ethylene vinyl acetate (EVA) in blood banks and the storage of frozen mixture will both expand in the next years. Additionally, as there are more blood banks globally, there is a growing need for storage of blood and blood components, which is growing both in awareness and demand. Due to a number of advantages such as chemical resistance, durability, clarity, and capacity to endure numerous sterilizing processes, the copolyester ether market is also expected to present a lucrative opportunity over the anticipated period.

North America held the largest share of the non-PVC IV bags market. The need for non-PVC IV containers, which can treat patients without endangering them, has surged in the United States as a result of stringent rules aimed at enhancing patient safety. Additionally, as the incidence of stomach cancer has grown over the past few years, so too has the demand for IV bags. For instance, according to the American Cancer Society, there will likely be 27,600 cases of stomach cancer diagnosed in the United States in 2020, which implies that 11,010 patients will pass away from the disease. Stomach cancer patients are unable to swallow food, thus they must fully rely on total parenteral nutrition to meet their nutritional needs and ensure their life.

Related Reports

Specimen Containers Market
Buy Now GET FREE SAMPLE
Clinical Trial Materials And Supplies Market
Buy Now GET FREE SAMPLE
Paroxysmal Nocturnal Hemoglobinuria Treatment Market
Buy Now GET FREE SAMPLE
Vascular Guidewires Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Non-PVC IV Bags Market

Product ID: SQMIG35B2050

$5,300
BUY NOW GET FREE SAMPLE